Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 1
2004 1
2005 1
2008 2
2009 1
2010 1
2012 1
2013 1
2014 2
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Improved procedure for fluorescence in situ hybridization on tissue microarrays.
Andersen CL, Hostetter G, Grigoryan A, Sauter G, Kallioniemi A. Andersen CL, et al. Cytometry. 2001 Oct 1;45(2):83-6. doi: 10.1002/1097-0320(20011001)45:2<83::aid-cyto1149>3.0.co;2-p. Cytometry. 2001. PMID: 11590619 Free article.
This technology enables researchers to perform gene copy number studies on very large series of archival formalin-fixed tissues using fluorescence in situ hybridization (FISH). However, the hybridization properties of individual archival …
This technology enables researchers to perform gene copy number studies on very large series of archival formalin-fixed tissues using …
Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology.
Fuller CE, Perry A. Fuller CE, et al. Brain Pathol. 2002 Jan;12(1):67-86. doi: 10.1111/j.1750-3639.2002.tb00424.x. Brain Pathol. 2002. PMID: 11770903 Free PMC article. Review.
Over the last decade, fluorescence in situ hybridization (FISH) has emerged as a powerful clinical and research tool for the assessment of target DNA dosages within interphase nuclei. Detectable alterations include aneusomies, deletions, gene amplifica …
Over the last decade, fluorescence in situ hybridization (FISH) has emerged as a powerful clinical and research …
DNA copy number analysis on tissue microarrays.
Kallioniemi A. Kallioniemi A. Methods Mol Biol. 2010;664:127-34. doi: 10.1007/978-1-60761-806-5_13. Methods Mol Biol. 2010. PMID: 20690059
Detection of DNA sequence copy number changes is essential in both clinical practice and basic research, especially in cancer research. The combination of fluorescence in situ hybridization (FISH) and tissue microarray (TMA) technology pr …
Detection of DNA sequence copy number changes is essential in both clinical practice and basic research, especially in cancer research. The …
Comparative multi-methodological measurement of ERBB2 status in breast cancer.
Ginestier C, Charafe-Jauffret E, Penault-Llorca F, Geneix J, Adélaïde J, Chaffanet M, Mozziconacci MJ, Hassoun J, Viens P, Birnbaum D, Jacquemier J. Ginestier C, et al. J Pathol. 2004 Mar;202(3):286-98. doi: 10.1002/path.1523. J Pathol. 2004. PMID: 14991893
Two global, extraction-based methods using real-time quantitative PCR on DNA (Q-PCR) or RNA (RQ-PCR) and two non-global, tissue-based methods, ie fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC), were used. ...To determin …
Two global, extraction-based methods using real-time quantitative PCR on DNA (Q-PCR) or RNA (RQ-PCR) and two non-global, tissue-based …
Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry.
Sato-Kuwabara Y, Neves JI, Fregnani JH, Sallum RA, Soares FA. Sato-Kuwabara Y, et al. BMC Cancer. 2009 Jan 7;9:6. doi: 10.1186/1471-2407-9-6. BMC Cancer. 2009. PMID: 19128465 Free PMC article.
It is important to know what prognostic factors can facilitate diagnosis, optimize therapeutic decisions, and improve the survival of these patients. A member of the epidermal growth factor receptor (EGFR) family, c-erbB-2, has received much attention because of its therap …
It is important to know what prognostic factors can facilitate diagnosis, optimize therapeutic decisions, and improve the survival of …
Cytogenetic prognostication within medulloblastoma subgroups.
Shih DJ, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM, Garzia L, Peacock J, Mack SC, Wu X, Rolider A, Morrissy AS, Cavalli FM, Jones DT, Zitterbart K, Faria CC, Schüller U, Kren L, Kumabe T, Tominaga T, Shin Ra Y, Garami M, Hauser P, Chan JA, Robinson S, Bognár L, Klekner A, Saad AG, Liau LM, Albrecht S, Fontebasso A, Cinalli G, De Antonellis P, Zollo M, Cooper MK, Thompson RC, Bailey S, Lindsey JC, Di Rocco C, Massimi L, Michiels EM, Scherer SW, Phillips JJ, Gupta N, Fan X, Muraszko KM, Vibhakar R, Eberhart CG, Fouladi M, Lach B, Jung S, Wechsler-Reya RJ, Fèvre-Montange M, Jouvet A, Jabado N, Pollack IF, Weiss WA, Lee JY, Cho BK, Kim SK, Wang KC, Leonard JR, Rubin JB, de Torres C, Lavarino C, Mora J, Cho YJ, Tabori U, Olson JM, Gajjar A, Packer RJ, Rutkowski S, Pomeroy SL, French PJ, Kloosterhof NK, Kros JM, Van Meir EG, Clifford SC, Bourdeaut F, Delattre O, Doz FF, Hawkins CE, Malkin D, Grajkowska WA, Perek-Polnik M, Bouffet E, Rutka JT, Pfister SM, Taylor MD. Shih DJ, et al. J Clin Oncol. 2014 Mar 20;32(9):886-96. doi: 10.1200/JCO.2013.50.9539. Epub 2014 Feb 3. J Clin Oncol. 2014. PMID: 24493713 Free PMC article.
Combined risk stratification models were designed based on clinical and cytogenetic biomarkers identified by multivariable Cox proportional hazards analyses. Identified biomarkers were tested using fluorescent in situ hybridization (FISH) on a nonoverlapping medullo …
Combined risk stratification models were designed based on clinical and cytogenetic biomarkers identified by multivariable Cox proportional …
A single slide multiplex assay for the evaluation of classical Hodgkin lymphoma.
Hollman-Hewgley D, Lazare M, Bordwell A, Zebadua E, Tripathi P, Ross AS, Fisher D, Adams A, Bouman D, O'Malley DP, Weiss LM. Hollman-Hewgley D, et al. Am J Surg Pathol. 2014 Sep;38(9):1193-202. doi: 10.1097/PAS.0000000000000242. Am J Surg Pathol. 2014. PMID: 24854113
The authors have investigated the utility of a novel hyperplexing technology, MultiOmyx, which may be applied to stain with >60 antibodies on single tissue sections from formalin-fixed paraffin-embedded tissue as an aid to the diagnosis of classical Hodgkin lymph …
The authors have investigated the utility of a novel hyperplexing technology, MultiOmyx, which may be applied to stain with >60 antibodie …
Modified fluorescence in situ hybridization methods using pathology archives.
Kitayama Y. Kitayama Y. Neuropathology. 2005 Sep;25(3):269-73. doi: 10.1111/j.1440-1789.2005.00628.x. Neuropathology. 2005. PMID: 16193846
However, as the identification of abnormal characteristics by conventional cytogenetic or molecular methods has been hampered by technical difficulties, minimal information has been available about specific chromosomal or locus-specific gene alterations. Recently, fluorescence
However, as the identification of abnormal characteristics by conventional cytogenetic or molecular methods has been hampered by technical d …
BCL2 positive and BCL6 negative diffuse large B cell lymphoma patients benefit from R-CHOP therapy irrespective of germinal and non germinal center B cell like subtypes.
Jovanovic MP, Mihaljevic B, Jakovic L, Martinovic VC, Fekete MD, Andjelic B, Antic D, Bogdanovic A, Boricic N, Terzic T, Jelicic J, Milenkovic S. Jovanovic MP, et al. J BUON. 2015 May-Jun;20(3):820-8. J BUON. 2015. PMID: 26214636 Free article.
METHODS: The immunohistochemical (IHC) expression of CD10, BCL6, MUM1 and BCL2 on paraffin-embedded formalin-fixed tumor samples from 103 centroblastic DLBCLs was analyzed. IHC expression of MYC and fluorescence in situ hybridization (FISH) for MYC and …
METHODS: The immunohistochemical (IHC) expression of CD10, BCL6, MUM1 and BCL2 on paraffin-embedded formalin-fixed tumor samples from 103 ce …
ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous.
Moelans CB, Holst F, Hellwinkel O, Simon R, van Diest PJ. Moelans CB, et al. PLoS One. 2013 Dec 18;8(12):e84189. doi: 10.1371/journal.pone.0084189. eCollection 2013. PLoS One. 2013. PMID: 24367641 Free PMC article.
Prevalence of ESR1 amplification in breast cancer is highly disputed and discrepancies have been related to different technical protocols and different scoring approaches. In addition, pre-mRNA artifacts have been proposed to influence outcome of ESR1 FISH analysis. …
Prevalence of ESR1 amplification in breast cancer is highly disputed and discrepancies have been related to different technical protocols
14 results